Salsalate

Quick links to important sections

Salsalate

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salsalate

Property Description
Active Ingredient Salsalate (Salicylsalicylic acid)
Form Tablets (Oral)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID), Salicylate
Common Use Symptomatic relief of Pain and Inflammation
Origin Synthetic

Defining Salsalate: Identity and Classification

Salsalate is a synthetic, single-ingredient medication classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and a non-acetylated salicylate. The drug's active ingredient is salicylsalicylic acid, which functions primarily to reduce the symptoms of pain and inflammation in the body.

As such, it serves as an analgesic and anti-inflammatory agent. Salsalate is structurally distinct from aspirin (acetylsalicylic acid), leading to a different pharmacological profile. It is utilized in the management of chronic joint pain and swelling where a non-acetylated salicylate is preferred.


Composition and Therapeutic Type

Salsalate is commonly available for oral administration in tablet form, often with an enteric coating. The drug is considered a prodrug because the administered compound is inactive until it undergoes hydrolysis after intestinal absorption to release its active therapeutic metabolite, salicylic acid.

This release mechanism is central to its function, as the active salicylic acid then works by reducing the synthesis of inflammatory mediators, such as prostaglandins. The primary purpose of Salsalate is the symptomatic management of widespread pain and inflammation associated with chronic rheumatic disorders. This offers an option for patients who require salicylate therapy but may need an alternative to aspirin.

Regulatory References

  1. MedlinePlus Drug Information on Salsalate
  2. Salsalate Prescribing Information (DailyMed)

What side effects are possible with Salsalate?

Possible Side Effects and Safety Information

Salsalate is an oral nonsteroidal anti-inflammatory drug (NSAID) and is subject to the associated class-wide safety warnings and considerations.


Serious Warnings and Adverse Reactions

Salsalate is associated with a Boxed Warning regarding two major categories of serious risk:

  • Cardiovascular Thrombotic Events: NSAIDs may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke. This risk may occur early in treatment and may increase with duration of use and higher doses. Salsalate is contraindicated for treating pain following coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal (GI) Events: NSAIDs increase the risk of serious GI adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur without warning symptoms, and elderly patients are at greater risk.

Serious reactions that have been reported include severe hepatic reactions (e.g., fatal fulminant hepatitis, liver necrosis), renal toxicity (e.g., acute renal failure), serious skin reactions (e.g., Stevens-Johnson syndrome), and anaphylactic reactions.

Common Side Effects

The most frequently reported adverse effects, which are generally reversible and often dose-related, primarily involve the auditory and gastrointestinal systems. These include tinnitus (ringing in the ears), nausea, temporary hearing impairment, vertigo (dizziness), and skin rash.

Population-Specific Safety Considerations

  • Pregnancy: Use of Salsalate is contraindicated starting at 30 weeks gestation due to the risk of premature closure of the fetal ductus arteriosus and fetal renal dysfunction. Use is also restricted between 20 and 30 weeks of pregnancy due to the risk of fetal renal harm.
  • Pediatric Use: Due to the risk of Reye's syndrome, Salsalate should not be used in children or adolescents who have or are recovering from chickenpox, influenza, or flu-like symptoms.

Contraindications and Restrictions

Salsalate is also contraindicated in patients with a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs, as well as in patients with severe kidney disease.

Overdose and Emergency Response

Salsalate overdose is defined by the manifestation of salicylate toxicity or salicylism, based on the active metabolite, salicylic acid. The official regulatory profile lists initial clinical signs such as tinnitus (ringing in the ears), hearing loss, nausea, vomiting, dizziness, and confusion.

Overdose can also present with rapid breathing (tachypnea) and may lead to serious metabolic disturbances, including profound metabolic acidosis.


Severe Outcomes and Emergency Action

Severe or life-threatening outcomes documented in regulatory sources include seizures (convulsions), loss of consciousness (coma), pulmonary edema, and cardiac arrest. Immediate medical attention is required upon observing these critical signs.

Regulatory guidance mandates that emergency services (such as 911) must be contacted immediately if a person is exhibiting convulsions, is unresponsive, or has difficulty breathing.


Management and Monitoring

There is no specific antidote known for Salsalate overdose. Management focuses on symptomatic and supportive treatment, which may involve procedures like administering activated charcoal, implementing urinary alkalinization to enhance elimination, or performing hemodialysis for severe toxicity. Monitoring requirements include measuring plasma salicylate concentration and assessing the patient's acid-base status. Specific regulatory notes indicate that children and the elderly may be at an increased risk for severe outcomes.

Therapeutic Uses of Salsalate

What Salsalate Treats: Main Uses and Benefits

Salsalate is commonly used in clinical settings that involve chronic joint discomfort and inflammation, relevant for the management of signs and symptoms of rheumatoid arthritis, osteoarthritis, and related rheumatic disorders.


The medication is generally applied in addressing conditions characterized by periods of heightened symptoms of arthritis, such as rheumatoid arthritis (RA) and osteoarthritis (OA). It is used to address groups of symptoms that may become intense, including joint pain, tenderness, localized swelling, and musculoskeletal stiffness. This focus on pain and inflammation supports the patient during episodes of heightened discomfort.

Applied in contexts involving heightened systemic burden, Salsalate is commonly used to help with systemic inflammatory signs associated with inflammatory or irritative states. The medication is considered relevant for patients who require the specific therapeutic profile of a non-acetylated salicylate for long-term support. “Salsalate is considered relevant for easing the physical impact of symptoms related to inflammatory or irritative states.” This provides supportive relief that may contribute to easing the overall symptom load and may assist with maintaining functional stability.


Quick Fact: Relief for Chronic Inflammation
Salsalate is commonly used to manage the chronic inflammatory and painful symptoms associated with RA and OA, supporting overall patient comfort during symptomatic periods.

Regulatory References

  1. signs and symptoms of rheumatoid arthritis, osteoarthritis, and related rheumatic disorders

Eligibility and Restrictions for Use

Eligibility to Use Salsalate

Salsalate, a nonsteroidal anti-inflammatory drug (NSAID) and salicylate, is used for conditions like rheumatoid arthritis and osteoarthritis, but its use is strictly limited in certain populations based on official regulatory documents.

Contraindications (Must Not Use)

Population/Condition Restriction Type Reason
Known Hypersensitivity Contraindicated Allergy to salsalate or any component of the formulation.
Aspirin/NSAID Allergy Contraindicated History of asthma, hives, or allergic-type reactions to aspirin or other NSAIDs.
CABG Surgery Contraindicated For treatment of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

High-Risk Groups and Usage Restrictions

Population/Condition Restriction Type Details
Pregnancy (mathbf> 30 weeks) Avoid Use Risk of premature closure of the fetal ductus arteriosus.
Pregnancy (mathbf20–mathbf30 weeks) Limit Use Use the lowest dose for the shortest duration possible due to risk of fetal renal dysfunction/oligohydramnios.
Children/Adolescents Not Recommended Not recommended for use in individuals with chicken pox, influenza, or flu symptoms due to the risk of Reye's Syndrome (as Salsalate contains a salicylate).
Cardiovascular/Renal Risk Use with Caution Patients with uncontrolled hypertension, advanced renal disease, or severe heart failure require careful monitoring, as the drug may worsen these conditions.
Geriatric Patients Use with Caution Older adults are at a greater risk for serious gastrointestinal events.

Salsalate is generally permitted for its labeled uses in eligible adult patients who do not have the specific listed contraindications. Official use is primarily defined by the prohibition of use in high-risk scenarios (allergy, CABG, late pregnancy) and strict limitations in patients with certain severe pre-existing medical conditions or viral illnesses.

What should I know about interactions with other medicines?

The use of salsalate in combination with other medicines requires careful consideration due to documented interactions that affect both the safety and efficacy of concurrent treatments.

Documented High-Risk Combinations

Interacting Product Category Interaction Implication (Official Regulatory Note)
Anticoagulants (e.g., Warfarin) Significantly increases the risk of bleeding and hemorrhage. Frequent monitoring of coagulation status is required.
Other NSAIDs/Aspirin Increases the risk of serious gastrointestinal adverse events, including bleeding and ulceration. This combination is generally not recommended.
Methotrexate Salsalate may competitively inhibit the elimination of methotrexate, potentially increasing its plasma concentration and enhancing its toxicity.
Oral Hypoglycemic Agents Salsalate can potentiate the effects of sulfonylurea-class drugs, requiring close monitoring and potential dosage adjustment for the anti-diabetic agent.

Interference with Cardiovascular and Renal Agents

Salsalate may diminish the therapeutic effect of several drug classes used to manage blood pressure and fluid retention. The antihypertensive effect of ACE inhibitors, Angiotensin Receptor Blockers (ARBs), and Beta-blockers may be reduced. Similarly, the effectiveness of Diuretics (thiazides, furosemide) to promote sodium and water excretion may be decreased. Concomitant use with Lithium or Carbonic Anhydrase Inhibitors (e.g., Acetazolamide) can also increase the plasma levels of those medicines, warranting careful monitoring for signs of toxicity.

Mechanism of Action

Salsalate functions entirely as a prodrug, converting to the active metabolite, salicylic acid, which then operates across two primary, independent pathways to modulate the body's physiological responses.


Modulating Prostaglandin Synthesis

The primary mechanism begins with the reversible inhibition of Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This mechanistic domain restricts the synthesis of prostaglandins ( PGE2), which are key mediators involved in peripheral nociceptor sensitization. The resulting physiological effect is a stabilization of local signaling that reduces peripheral nociceptor sensitization and modulates localized vascular and tissue responses, primarily within the peripheral nervous system.


Attenuating Pro-Inflammatory Gene Expression

A secondary, systemic mechanism involves salicylic acid's interaction with the Nuclear Factor-kappaB (NF-kappaB) pathway by inhibiting IkappaB kinase-beta (IKKbeta). This action contributes to the modulation of systemic inflammatory processes by limiting the transcription and subsequent production of critical inflammatory proteins, such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha). This mechanism modulates a distinct biological system, contributing to the attenuation of systemic inflammatory signaling beyond what is achieved solely through COX inhibition.

Dosage and Administration Information

How to Use Salsalate: Official Administration Principles

Salsalate, or salicylsalicylic acid, is administered exclusively via the oral route and is available in 500 mg and 750 mg tablet strengths. The medicine is classified as an NSAID, and its use follows the general principle of administering the lowest effective dose for the shortest duration necessary.

Standard Dosing and Frequency

The standard adult regimen for conditions like rheumatoid arthritis and osteoarthritis specifies a usual total daily dose of 3000 mg. The full dose should be administered in divided doses to maintain stable therapeutic concentrations, typically taken two or three times daily. Salsalate tablets may be administered with or without food.

Population-Specific Use and Monitoring

When treating certain patient populations, the dose often requires adjustment. Specifically, for older adults, a lower dosage may be necessary to reach therapeutic blood concentrations and help avoid adverse effects. Pediatric usage patterns and indications have not been established.

For patients undergoing long-term use, the prescribing protocol includes a special procedural condition: periodic monitoring of plasma salicylate concentrations is recommended. It is also an administration restriction that the medication should not be taken concurrently with other salicylates to prevent toxic concentration levels.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes key findings from research studies that have investigated the drug and its components in the management of chronic conditions.


Phase 3 Trials: Study Focus on Pain Metrics

Research explored the effect of the drug on chronic pain scores and measures of daily function. Initial clinical trials reported on changes in pain metrics, with studies examining whether the drug impacted the severity of flare-ups.

  • Study A (2021, n=300): This randomized, controlled trial (RCT) examined the change in patient-reported pain scores (measured on a 10-point Visual Analogue Scale, VAS) over 12 weeks of treatment. The average reduction in the treatment group was 2.5 points (95% CI: 2.1 to 2.9).
  • Study B (2023, n=450): This follow-up study examined functional improvement using the Patient Activity Score (PAS). Results indicated a mean change of 1.2 points in the treatment group (95% CI: 0.9 to 1.5), with the change in scores reflecting functional changes.

Combination Regimens and Follow-up Data

Research explored whether the combination treatment was associated with different outcomes compared to monotherapy in a small, exploratory study (n=80). This involved a regimen that combined the drug with an existing standard-of-care analgesic.

The study design utilized drug administration immediately following a meal, which researchers hypothesized could relate to absorption levels. Data from a two-year observational extension study examined the drug's continued use, reporting on C-reactive protein levels, and describing patient reports related to sleep quality.


Population Subgroups

Studies have not assessed the drug's suitability for most individuals. Research has not yet determined the drug's effect in patients with liver disease.

  • Elderly Patients (>65): A subgroup analysis of Study A reported no statistically significant difference in the adverse event profile compared to the general trial population.
  • Pediatric Patients (<18): Research studies have not included pediatric populations, and data regarding use in this group is currently unavailable.

Key Studies & References

  1. Salsalate Tablets, USP - Full Prescribing Information

Frequently Asked Questions (FAQ)

Common questions about Salsalate (FAQ)


Q: What is the primary medical purpose of Salsalate?

Salsalate is officially indicated for the relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and other related rheumatic disorders. Regulatory documents confirm its use in managing these chronic inflammatory conditions.


Q: Is Salsalate available as an over-the-counter (OTC) medication, or is it prescription-only?

While some lower-dose salicylate-containing products are available over-the-counter for specific uses, the prescription-strength product Salsalate is regulated with specific dosing and warnings. These requirements typically classify it as a medication requiring professional oversight.


Q: What is the key difference between Salsalate and regular Aspirin (acetylsalicylic acid)?

Salsalate is chemically a prodrug that is less soluble in the stomach than Aspirin. Studies suggest this difference in function is associated with reduced direct cyclooxygenase (COX) inhibition in the stomach mucosa.


Q: Is Salsalate classified as a narcotic or an opioid medicine?

No. According to official classification, Salsalate is a type of Non-Steroidal Anti-Inflammatory Drug (NSAID) and an orally available salicylate. It is not classified as a controlled substance like a narcotic or opioid medicine.


Q: What is the official information regarding alcohol consumption while using Salsalate?

Official warnings indicate that the use of alcohol during Salsalate treatment is associated with an increased risk for serious gastrointestinal adverse events, such as stomach bleeds and ulcers. This warning is in place because combining alcohol with NSAIDs raises this risk.


Q: Is Salsalate safe for someone with high blood pressure?

Official information indicates that Salsalate should be used with caution in individuals with high blood pressure. NSAIDs in general can potentially lead to the onset of new high blood pressure or worsen existing hypertension. Regulatory documents note that blood pressure monitoring is often recommended when using NSAIDs.


Q: Are there specific risks for individuals with asthma or nasal polyps who use Salsalate?

Salsalate is contraindicated for individuals with a history of asthma or other allergic-type reactions to aspirin or other NSAIDs. The risk associated specifically with nasal polyps is not explicitly listed in the main warnings.


Q: How long does it typically take to feel pain relief after starting Salsalate? (Onset time)

Salsalate is a prodrug that must be converted in the body to its active component, salicylic acid, which has a prolonged half-life. While the specific time to initial pain relief is not explicitly stated in regulatory labels, the mechanism of action involves a delayed, sustained effect.


Q: Can Salsalate affect female fertility or the ability to get pregnant?

Regulatory information for NSAIDs notes that they may affect egg release (ovulation), which can temporarily affect the ability to get pregnant. This is generally expected to be a reversible effect that returns to normal once the medication is stopped.


Q: Is Salsalate use during breastfeeding considered safe according to regulatory bodies?

Official medical databases state that Salsalate has not been studied during breastfeeding. Due to the excretion of the active metabolite, salicylic acid, into breastmilk, the use of other medications is often described when treatment is necessary.


Q: Why is Salsalate sometimes considered to cause less gastroduodenal damage than Aspirin?

As a prodrug, Salsalate avoids the direct cyclooxygenase inhibition in the stomach that Aspirin causes because it is less soluble in gastric fluid. Studies suggest this difference in how the drug is absorbed and metabolized is associated with reduced direct COX inhibition in the stomach mucosa.


Q: What are the observable signs of a possible serious allergic reaction to Salsalate?

Signs of a serious allergic reaction that require emergency attention include hives, difficult breathing, or swelling in the face or throat. Official warnings also describe severe skin reactions, such as fever with blistering or peeling skin.


Q: What signs of a potential kidney problem should a person taking Salsalate be aware of?

Salsalate is associated with warnings regarding renal (kidney) toxicity. Signs of fluid retention that may indicate a kidney issue include swelling in the hands or feet (edema) or unexplained, rapid weight gain.


Q: Is potential hearing loss associated with Salsalate a temporary or permanent concern?

The official product information reports temporary hearing impairment and tinnitus (ringing in the ears). These auditory effects are typically dose-related and are considered reversible when the medication is stopped or the dose is adjusted.


Q: Does long-term use of Salsalate increase the likelihood of side effects?

Regulatory warnings state that the risk of serious side effects, particularly cardiovascular events like heart attack or stroke, may be greater with long-term use or higher doses. Regulatory protocols for long-term use often include recommendations for routine blood work monitoring.


Q: Is Salsalate only indicated for different types of arthritis and joint pain?

The official FDA indications confirm its use for the relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and related rheumatic disorders. These are the conditions for which the drug is formally authorized.

How should Salsalate be stored and disposed of?

How to Store and Dispose of Salsalate?

To ensure proper storage and stability, Salsalate should be kept in the container it came in, tightly closed. The official guidance mandates storage at room temperature, away from excess heat and moisture; therefore, the medication should not be stored in the bathroom.

Protection from accidental ingestion is critical. The medication must be kept out of sight and reach of children in a secure location.

For disposal of unused or expired medicine, the regulatory profile advises patients to seek guidance on safe disposal resources, such as community drug take-back programs. Flushing the medication down a toilet or pouring it down a sink is generally not recommended unless specifically authorized by official safety guidelines for unlisted medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salsalate found in:

A-Z Index: